Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer
Takahiko Murayama, Jun Nakayama, Xinpei Jiang, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 468-491
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70
Cellular responses to RNA damage
Jacqueline Cordes, Shubo Zhao, Christoph Engel, et al.
Cell (2025) Vol. 188, Iss. 4, pp. 885-900
Open Access | Times Cited: 2
Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
Kyle A. Cottrell, Sua Ryu, Jackson R. Pierce, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 986-1003
Open Access | Times Cited: 15
Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer
Anna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 9
Multi-omics reveals lactylation-driven regulatory mechanisms promoting tumor progression in oral squamous cell carcinoma
Fengyang Jing, Lijing Zhu, Jianyun Zhang, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Targeting TREX1 induces innate immune response in drug-resistant Small Cell Lung Cancer
Takahiko Murayama, Navin R. Mahadevan, Catherine B. Meador, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 9, pp. 2399-2414
Open Access | Times Cited: 6
Advancements and Challenges of R-loops in Cancers: Biological Insights and Future Directions
Dengxiong Li, Fanglin Shao, Xinrui Li, et al.
Cancer Letters (2024) Vol. 610, pp. 217359-217359
Closed Access | Times Cited: 5
Targeting Hepatocellular Carcinoma Growth: Haprolid’s Inhibition of AKT Signaling Through DExH-Box Helicase 9 Downregulation
Jun Xing, Xiaoxi Feng, Rutong Zhang, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 443-443
Open Access
Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy
Ruirui Wang, Xin Dong, Xiongjian Zhang, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 3, pp. 958-973
Open Access
Loss of p53 Induces Tolerance to Viral Mimicry as a Mechanism of Immune Evasion in Early Tumorigenesis
Takahiko Murayama, Israel Cañadas
Cancer Discovery (2025) Vol. 15, Iss. 4, pp. 670-672
Closed Access
The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts
Xiaoqiang Wang, Jiaxing Jin, Han Yan, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 793
Closed Access
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9
Matthew H. Daniels, Jennifer Castro, Young‐Tae Lee, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Competitive binding between DDX21 and SIRT7 enhances NAT10-mediated ac4C modification to promote colorectal cancer metastasis and angiogenesis– DDX21 promotes colorectal cancer metastasis
Angxi Song, Bowen Liu, Wenjing Li, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein
Kailin Chen, Sai-Wei Huang, Ji‐Jin Yao, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101111-101111
Closed Access | Times Cited: 3
Exploring the role of TIGIT in patients with Small Cell Lung Cancer as a novel predictor of prognosis and immunotherapy response
Li Liu, Peng Wu, Bingzhi Wang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
20 years of histone lysine demethylases: From discovery to the clinic and beyond
Zach H. Gray, M. Honer, Pooja Ghatalia, et al.
Cell (2025) Vol. 188, Iss. 7, pp. 1747-1783
Closed Access
Targeting the DHX9 RNA Helicase to Induce Antitumor Immunity in Small-Cell Lung Cancer
Katherine B. Chiappinelli
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 389-391
Closed Access | Times Cited: 2
Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer
Beibei Sun, Guizhen Wang, Si-Chong Han, et al.
Cancer Letters (2024) Vol. 592, pp. 216929-216929
Closed Access | Times Cited: 2
Stimulation of cGAS-STING pathway as a challenge in the treatment of small cell lung cancer: a feasible strategy?
Giulia Miglietta, Marco Russo, Giovanni Capranico, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 2
Activation of PKR by a short-hairpin RNA
Kyle A. Cottrell, Sua Ryu, Helen Donelick, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Recent advances in immunotherapy for small cell lung cancer
Ziyuan Ren, Shijie Shang, Dawei Chen
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 2
Evolution of Repetitive Elements, Their Roles in Homeostasis and Human Disease, and Potential Therapeutic Applications
Jeffrey M. Snowbarger, Praveen Koganti, Charles Spruck
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1250-1250
Open Access | Times Cited: 1
DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: A Comprehensive Analysis and Experimental Validation
Nanbin Liu, Qian Wang, Peng‐Peng Zhu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 20, pp. 6594-6615
Open Access | Times Cited: 1
Revitalizing antitumor immunity: Leveraging nucleic acid sensors as therapeutic targets
Danfeng Liu, Wei He, Leilei Yang
Cancer Letters (2024) Vol. 588, pp. 216729-216729
Closed Access
Page 1 - Next Page

Scroll to top